Ishan Patel, MD
Hospitalist · Richmond, VANPI 1710328505
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Eisai Inc. at 26.5% of the total. Reporting peaked in 2022 at $344 and has fallen 52.6% since, to $163 in 2025. Among hospitalist clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 8 payments — averaging $106.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$226
- W. L. Gore & Associates, Inc.$138
- AstraZeneca$125
- AbbVie$120
- Baxter Healthcare$90
- Medtronic$81
- plus $73 from 1 others
What the payments were for
- Food & beverage$853100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 2 | $226 |
| W. L. Gore & Associates, Inc. | 1 | $138 |
| AstraZeneca | 1 | $125 |
| AbbVie | 1 | $120 |
| Baxter Healthcare | 1 | $90 |
| Medtronic | 1 | $81 |
| GSK | 1 | $73 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fycompa$226
- GORE CARDIOFORM Septal Occluder$138
- FARXIGA$125
- DALVANCE$120
How this compares
$853 in reported general payments places this provider in the 90th percentile of 539 hospitalist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 28 | $416 |
| Bumetanide | 13 | $248 |
| Fluoxetine Hcl | 11 | $226 |
| Cefdinir | 14 | $204 |
| Pantoprazole Sodium | 20 | $191 |
| Ondansetron OdtOndansetron | 13 | $190 |
| Prednisone | 15 | $70 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $46 |
| Doxycycline Hyclate | 11 | $36 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Richmond
- Emily KinseyRichmond$5K
- Anusha KanagalaRichmond$666
- Ruksana JabeenRichmond$595
- Yuri MaricichCharlottesville$212K
- Dennis NguyenSpringfield$8K
- Muhammad AfridiWinchester$7K
- Lana WahidRoanoke$6K
- Mohammed AmerNewport News$5K
- Jill CouchNorton$3K
- John MelsonCharlottesville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.